To assess the effective binding of STAT3 with CTTNBP2 CRE, we performed luciferase assays in NB cell lines in combination with STAT3 silencing, using both long (Fig. 1c) and short constructs (Supplementary Fig. 5A). The gene discussed is STAT3; the disease is neuroblastoma.